Access Dermatology March Update

1. Topical heparin and levomenol combination reduces pruritus in atopic dermatitis
2. Differences in FCER1A N222K mutation between Japanese and Polish patients with atopic dermatitis
3. A novel biomarker identifies Bak as a candidate serum biomarker in melanoma
4. Comparison of drug survival rates for adalimumab, etanercept and infliximab in psoriasis patients
5. Benefit-risk analysis favors adalimumab over methotrexate in psoriasis study
6. Serum prolactin levels may be a proxy measure of psoriasis disease activity
7. HLA-DR alleles are associated with skin warts induced by human papillomavirus
8. Genital psoriasis: A literature review of its epidemiology, presentation, diagnosis and treatment
9. Social and environmental factors may influence pediatric eczema expression: U.S. national data survey
10. Serum neopterin levels in spontaneous urticaria and atopic dermatitis
11. Study suggests link between psoriasis, atherosclerosis and erectile dysfunction
12. Full spectrum light phototherapy shows efficacy and safety in atopic dermatitis
13. Facial melanoma management outcomes and the role of sentinel lymph node biopsy
14. Study shows no significant association between vitiligo and thyroid dysfunction
15. AAD News: Sun avoidance to slow down aging may predispose women to vitamin D deficiency
16. AAD News: Study identifies predictors of response to treatments for Sezary syndrome
17. AAD News: Atopic dermatitis increases risk for infective endocarditis in children with cardiac anomalies
18. AAD News: History of nevus-associated melanoma predisposes patients to second malignancy of the same origin
19. AAD News: TNF inhibitors do not reduce MI risk or increase malignancy risk in patients with psoriasis

To be able to read these news and more, please visit www.accessdermatology.com